微信小陈
微信小章| 产品名称： | Mycoplasma hominis |
|---|---|
| 商品货号： | TS163758 |
| Deposited As： | Mycoplasma hominis (Freundt) Edward |
| Strain Designations： | Sprott |
| Isolation： | Clinical isolate |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®： | no |
| Type Strain： | no |
| Antibiotic Resistance： | Tetracycline-resistant. |
| Comments： | Genetic transformation |
| Medium： | ATCC® Medium 243: Mycoplasma medium |
| Growth Conditions： | Temperature: 37°C
Atmosphere: 5% CO2 |
| Name of Depositor： | G Furness |
| References： | Furness G, Cerone AM. Preparation of competent single-cell suspensions of Mycoplasma hominis tets and Mycoplasma salivarium tets for genetic transformation to tetracycline resistance by DNA extracted from Mycoplamsa hominis tetr. J. Infect. Dis. 139: 444-451, 1979. PubMed: 438545 Cerone-McLernon AM, Furness G. The preparation of transforming DNA from Mycoplasma hominis strain Sprott tetr and quantitative studies of the factors affecting the genetic transformation of Mycoplasma salivarium strain S9 tets to tetracycline resistance. Can. J. Microbiol. 26: 1147-1152, 1980. PubMed: 7459727 |